Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
38.63
-0.27 (-0.69%)
Dec 20, 2024, 4:00 PM EST - Market closed
Xenon Pharmaceuticals Market Cap
Xenon Pharmaceuticals has a market cap or net worth of $2.95 billion as of December 20, 2024. Its market cap has increased by 15.30% in one year.
Market Cap
2.95B
Enterprise Value
2.15B
1-Year Change
15.30%
Ranking
Category
Stock Price
$38.63
Market Cap Chart
Since November 5, 2014, Xenon Pharmaceuticals's market cap has increased from $142.20M to $2.95B, an increase of 1,971.12%. That is a compound annual growth rate of 34.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 2.95B | -2.28% |
| Dec 29, 2023 | 3.01B | 22.21% |
| Dec 30, 2022 | 2.47B | 53.02% |
| Dec 31, 2021 | 1.61B | 199.33% |
| Dec 31, 2020 | 538.40M | 58.77% |
| Dec 31, 2019 | 339.10M | 112.87% |
| Dec 31, 2018 | 159.30M | 213.58% |
| Dec 29, 2017 | 50.80M | -63.13% |
| Dec 30, 2016 | 137.80M | 19.20% |
| Dec 31, 2015 | 115.60M | -58.73% |
| Dec 31, 2014 | 280.10M | 96.98% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Envista Holdings | 3.10B |
| Denali Therapeutics | 3.09B |
| Veracyte | 3.03B |
| Janux Therapeutics | 2.98B |
| BrightSpring Health Services | 2.97B |
| Warby Parker | 2.92B |
| Edgewise Therapeutics | 2.92B |
| Amicus Therapeutics | 2.91B |